Celldex Therapeutics earnings were -$157.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CLDX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$47.1M, up 11.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLDX reported annual earnings of -$157.9M, with 11.6% growth. The next CLDX earnings date is May 5, 2025.
Celldex Therapeutics Earnings Reports & History FAQ
What were Celldex Therapeutics's earnings last quarter?
On CLDX's earnings call on Invalid Date, Celldex Therapeutics (NASDAQ: CLDX) reported Q4 2024 earnings per share (EPS) of -$0.71, up 15.48% year over year. Total CLDX earnings for the quarter were -$47.09 million. In the same quarter last year, Celldex Therapeutics's earnings per share (EPS) was -$0.84.
The next CLDX earnings date is Invalid Date. Add CLDX to your watchlist to be reminded of Celldex Therapeutics's next earnings date.
Is Celldex Therapeutics profitable or losing money?
As of the last Celldex Therapeutics earnings report, Celldex Therapeutics is currently losing money. Celldex Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$157.86 million, a 11.62% increase year over year.
What was CLDX's earnings growth in the past year?
As of Celldex Therapeutics's earnings date in Invalid Date, Celldex Therapeutics's earnings has grown year over year. CLDX earnings in the past year totalled -$157.86 million.
What are Celldex Therapeutics's earnings expectations?
The current EPS estimate for Celldex Therapeutics's earnings report in Invalid Date is -$0.69.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.